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Letters to the Editor
Physiologic Timing
for Objective Checking of
Instantaneous Maximal Aortic Stenotic Area
Feuchtner et al. (1) recently proposed a new and successful method
for imaging and evaluating aortic valve area (AVA) in aortic
stenosis (AS) using a 16-row multislice computed tomography
MSCT scanner. The investigators reasonably indicated that
MSCT was not a primary diagnosis imaging technique, recalling
the feasibility and cost-effectiveness of the usual echo-Doppler
techniques in clinical practice. I agree with these general consid-
erations and appreciated the study. Some comments are needed
about the methodology they used to acquire images.
On the one hand, an obvious discrepancy exists between the
described method in their study, assuming an approximate value of
50 ms for isovolumetric contraction (IC), and the diagram shown
in their Figure 1 (top row). This 50-ms time interval is stated to be
subtracted from the duration of the cardiac cycle for the recon-
struction of the first image. Everyone may agree with the 50-ms
approximation for IC. Figure 1, however, shows that the so-called
IC starts with QRS of the electrocardiogram (ECG) and covers
the full duration of the QRS complex. This illustration raises a
didactical issue: the total QRS duration normally ranges about
120 ms and, thus; widely exceeds 50 ms. The QRS onset is the
initial marker of the pre-ejection period, of which IC is only a
component, succeeding to the electromechanical delay, and ending
with the opening of the aortic valve, marker of ejection onset. The
IC has a physiologic interest because it corresponds to the rapid
rise of left ventricular pressure, which requires mitral valve closure
and lags behind QRS onset.
In brief, if only 50 ms were subtracted, the latest part of
pre-ejection, which is precisely IC, would be integrated into the
duration of the cardiac cycle. This may be of limited consequence
on final imaging measurements, but, regretably, it makes Figure 1
erroneous and confuses the reader.
On the other hand, MSCT enables one to directly image
instantaneous AVA, which varies along systole. The assumption
that maximal AVA coincides with the maximal pressure drop has
been substantiated by studies using the continuity equation over
systole (2). No significant difference was reported either between
timings of maximal Doppler jet flow AVA and maximal pressure
gradient (3). Rather than studying reconstructed images generated
during the entire mid-late systole every 50 ms in order to identify
the phase of maximal AVA (1), a less empiric way of selecting
maximal AVA would consist of triggering the image at peak
velocity of the stenotic jet recorded by continuous-wave Doppler.
Peak velocity has a reproducible timing (3). The reliable ultrasound
assessment of AVA it provides could easily be applied to other
imaging modalities. Advantages of this specific timing are 3-fold:
1) it relies on a physiologic substrate; 2) it enables comparison
between laboratories; and 3) it facilitates follow-up of patients by
relying on an objective landmark.
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